Busse Falko's most recent trade in Bruker Corp was a trade of 6,030 Common Stock done . Disclosure was reported to the exchange on Aug. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 6,030 | 38,889 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 5,486 | 5,486 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Sale of securities on an exchange or to another person at price $ 86.06 per share. | 28 Feb 2024 | 13,852 | 47,129 (0%) | 0% | 86.1 | 1,192,103 | Common Stock |
| Bruker Corp | Busse Falko | PRESIDENT, BIOSPIN GROUP | Sale of securities on an exchange or to another person at price $ 84.97 per share. | 28 Feb 2024 | 12,770 | 34,359 (0%) | 0% | 85.0 | 1,085,067 | Common Stock |
| Bruker Corp | Busse Falko | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 12,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Busse Falko | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.82 per share. | 28 Feb 2024 | 12,000 | 44,859 (0%) | 0% | 19.8 | 237,840 | Common Stock |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 7,097 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.19 per share. | 28 Feb 2024 | 7,097 | 51,956 (0%) | 0% | 22.2 | 157,482 | Common Stock |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,641 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.95 per share. | 28 Feb 2024 | 4,641 | 60,981 (0%) | 0% | 42.0 | 194,690 | Common Stock |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,384 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Busse Falko | PRESIDENT, BIOSPIN GROUP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.02 per share. | 28 Feb 2024 | 4,384 | 56,340 (0%) | 0% | 34.0 | 149,144 | Common Stock |
| Bruker Corp | Busse Falko | PRESIDENT, BIOSPIN GROUP | Sale of securities on an exchange or to another person at price $ 84.48 per share. | 28 Feb 2024 | 1,500 | 32,859 (0%) | 0% | 84.5 | 126,720 | Common Stock |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 4,526 | 32,859 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 4,154 | 4,154 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 4,719 | 4,719 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | Falko Busse | PRESIDENT, BIOSPIN GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 4,658 | 28,333 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Falko Busse | President, BioSpin Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 4,153 | 4,153 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | Falko Busse | President, BioSpin Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 3,321 | 23,675 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Falko Busse | President, BioSpin Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 5,828 | 5,828 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | Falko Busse | President, BioSpin Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 5,173 | 20,354 (0%) | 0% | 0 | Common Stock |